Casma Therapeutics Funding: $162M Raised, Grant (2026)
Casma Therapeutics is based in Boston. It has raised $162M in total funding. Latest round: Grant.
Casma Therapeutics funding overview
Casma Therapeutics is based in Boston. Casma Therapeutics has raised $162M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Grant announced in March 2026. The round record for Casma Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Third Rock Ventures, The Column Group, Mirae Asset, Eventide Funds, The Chernin Group, Amgen Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
Casma Therapeutics at a glance
Total raised
$162M
Latest round
Grant
Latest round date
March 2026
Headquarters
Boston
Notable investors
Third Rock Ventures, The Column Group, Mirae Asset, Eventide Funds, The Chernin Group, Amgen Ventures, The Michael J. Fox Foundation for Parkinson's Research, Astellas Venture Management
Frequently asked about Casma Therapeutics funding
How much has Casma Therapeutics raised?
Casma Therapeutics has raised $162M in total disclosed funding across the rounds on record.
Who has invested in Casma Therapeutics?
Third Rock Ventures, The Column Group, Mirae Asset, Eventide Funds, The Chernin Group, Amgen Ventures are named among the investors backing Casma Therapeutics.
What was the latest Casma Therapeutics funding round?
The most recent disclosed round is a Grant, announced in March 2026.
Where is Casma Therapeutics based?
Casma Therapeutics is based in Boston.
When did Casma Therapeutics last raise?
The last disclosed Casma Therapeutics round closed in March 2026 at Grant.
Round data for Casma Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Boston and backer lists below.
